$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What kind of important antibacterial drugs does linezolid (Siwo) belong to and its hierarchical management status?
2026-02-01 22:25:32
Check Details
Patients’ personal experiences after taking Ribociclib (Kaillon) for one year, including efficacy stability and side effects
2026-02-01 22:25:32
Check Details
Analysis of which immune antibody type Cemiplimab, as a PD-1 antibody drug, belongs to
2026-02-01 22:25:32
Check Details
Recommended dosage of daprodustat and individualized dosage adjustment plans for different patient groups
2026-02-01 22:25:32
Check Details
Differences in efficacy and indications between durvalumab (durvalumab) and pembrolizumab
2026-02-01 22:25:32
Check Details
Are zolbetuximab and zolbetuximab the same drug and explanation of naming differences
2026-02-01 22:25:32
Check Details
Does EIKANCE 0.01% Atropine Sulfate Eye Drops require refrigeration and the impact of storage conditions on its efficacy?
2026-02-01 22:25:32
Check Details
How to take voclosporin most correctly, full analysis of dosage, taking time and precautions
2026-02-01 22:25:32
Check Details
Ponatinib is the first generation of targeted drugs and its role in the treatment of chronic myelogenous leukemia
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of Shafinamide Tablets (Siddaco) and Rasagiline, patient experience and clinical recommendations
2026-02-01 22:25:32
Check Details
Tarlatamab-Imdelltra one-time treatment cost, patient medication cost and market price analysis
2026-02-01 22:25:32
Check Details
Summary of telisotuzumab-EMRELIS clinical trial data and efficacy analysis for different indications
2026-02-01 22:25:32
Check Details
1
2
...
2431
2432
2433
2434
2435
2436
2437
2438
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
2
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
3
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
4
ROS and Cancer: The Potential of Natural Antioxidants
5
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
6
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
7
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
8
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
9
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
10
From Causes to Treatments—Exploring Medical Breakthroughs
11
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
12
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship